Article
13 Mar 2024
Viking Therapeutics Announces $632.5 Million Public Offering Of Common Stock
AUTHORS CONTENT
Article
11 Mar 2024
NLX Raises $12 Million Series A
Article
08 Mar 2024
USPTO Offers Guidance On Inventorship For AI-Human Collaborations
Article
05 Mar 2024
Q4 2023 Quarterly VC Update: Bobby Yazdani On The State Of Venture Capital Investing
Article
05 Mar 2024
Brii Biosciences Announces Agreements To Acquire VBI Vaccines' IP Rights In BRII-179
Article
01 Mar 2024
FCC Proposes New Regulatory Framework For In-Space Servicing, Assembly And Manufacturing Operations
Article
14 Feb 2024
UPOV Releases Explanatory Notes Further Defining Protection For Essentially Derived Varieties
Article
13 Feb 2024
Cooley, Cybersecurity Leaders File Brief Opposing SEC's SolarWinds Cyberattack Case
Article
02 Feb 2024
Yieldstreet Completes Acquisition Of Cadre
Article
30 Jan 2024
Securities Litigation + Enforcement Highlights From Q4 2023
Article
23 Jan 2024
Immediate Obligations For Employers With Noncompete, Customer Nonsolicitation Provisions For California Employees
Article
15 Jan 2024
Allorion Therapeutics Announces Exclusive Option, Global License Agreement With AstraZeneca
Article
09 Jan 2024
MannKind Announces Up To $200 Million Royalty Purchase Agreement With Sagard Healthcare
Article
09 Jan 2024
Annual SEC Filing Deadline For Venture, Private Equity Funds Is February 14, 2024
Article
05 Jan 2024
US Tax Court: Limited Partners May Be Subject To Self-Employment Tax
Article
04 Jan 2024
Beneficial Ownership Reporting Requirements Under The Corporate Transparency Act: What You Need To Know
Article
04 Jan 2024
FCA Consults Further On The New UK Listing Regime
Article
28 Dec 2023
Year-End Tasks For US Employers Facing Compliance Obligations
Article
06 Dec 2023
Provisional Agreement Reached On Proposed EU Cyber Resilience Act
Article
10 Nov 2023
California Employers Facing New Employment Laws For 2024